Literature DB >> 35903662

Adjuvant Radiotherapy in Grade II, Atypical Meningioma of the Skull Base.

David P Bray1, Bryan E Buster1, Joseph W Quillin1, Robert H Press2, Bree R Eaton3, Jeffrey J Olson1.   

Abstract

Introduction  Atypical meningiomas (AM) are meningiomas that are more aggressive than their grade-I counterparts and have a higher rate of recurrence. The effect of adjuvant radiotherapy (ART) on AM of the skull base is not defined. Methods  A retrospective review of all AM's of the skull base primarily resected at our institution from 1996 to 2018 was completed. ART was defined as radiotherapy (RT) that occurred within 6 months of initial resection, regardless of Simpson's grade. Minimum time length of follow-up after resection was 2 years. Statistical analysis was performed using SAS. Results  There were a total of 59 skull base-located (SBL) AMs resected at our institution from 1996 to 2018. The average age of our cohort was 53.2 years. Gross total resection, defined as Simpson's grades I to III resection, was achieved in 36 (61%) of cases. Thirty-five of 59 (59%) patients received ART. Recurrence was observed in 14 patients (24%), and mean time to recurrence was 63.8 months. Patients who received ART had a lower observed rate of recurrence (8 vs. 46%); however, time to recurrence was not significantly different between the two populations. Conclusion  We observe that AM in the skull base location have higher recurrence rates than we would expect from grade-I meningioma. These data suggest that ART may offer benefit to the overall observed frequency of recurrence of SBL AM; however, the time to recurrence between patients who received ART and those who did not was not statistically significant in survival analysis. Thieme. All rights reserved.

Entities:  

Keywords:  atypical meningioma; meningioma; radiotherapy; skull base

Year:  2021        PMID: 35903662      PMCID: PMC9324308          DOI: 10.1055/s-0041-1735879

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  24 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  A revolution in skull base surgery: the quality of life matters!

Authors:  James I Ausman
Journal:  Surg Neurol       Date:  2006-06

Review 3.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Authors:  Quinn T Ostrom; Haley Gittleman; Gabrielle Truitt; Alexander Boscia; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-10-01       Impact factor: 12.300

Review 4.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

5.  Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies.

Authors:  Naoya Hashimoto; Carter S Rabo; Yoshiko Okita; Manabu Kinoshita; Naoki Kagawa; Yasunori Fujimoto; Eiichi Morii; Haruhiko Kishima; Motohiko Maruno; Amami Kato; Toshiki Yoshimine
Journal:  J Neurosurg       Date:  2011-12-16       Impact factor: 5.115

6.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  World Health Organization Grades II and III meningiomas are rare in the cranial base and spine.

Authors:  Burak Sade; Ali Chahlavi; Ajit Krishnaney; Sean Nagel; Eugene Choi; Joung H Lee
Journal:  Neurosurgery       Date:  2007-12       Impact factor: 4.654

Review 8.  Atypical and malignant meningiomas: a clinicopathological review.

Authors:  A Mahmood; D V Caccamo; F J Tomecek; G M Malik
Journal:  Neurosurgery       Date:  1993-12       Impact factor: 4.654

9.  Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).

Authors:  Damien C Weber; Carmen Ares; Salvador Villa; Saskia M Peerdeman; Laurette Renard; Brigitta G Baumert; Anna Lucas; Theo Veninga; Alessia Pica; Sarah Jefferies; Umberto Ricardi; Raymond Miralbell; Jean-Jacques Stelmes; Yan Liu; Laurence Collette; Sandra Collette
Journal:  Radiother Oncol       Date:  2018-06-28       Impact factor: 6.280

Review 10.  Radiation Treatment for WHO Grade II and III Meningiomas.

Authors:  Brian P Walcott; Brian V Nahed; Priscilla K Brastianos; Jay S Loeffler
Journal:  Front Oncol       Date:  2013-09-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.